Field Technologies News

  1. Mettler-Toledo Hi-Speed Ensures Precision Accuracy For AstraZeneca 6/10/2009
    Mettler-Toledo Hi-Speed, the worldwide leader of in-line checkweighers, installed two customized Starweigh™ checkweighers to ensure the accuracy of daily dose bottles for clinical trials. Clinical drug trials provide a precisely-calibrated daily dose to participants – too little, and the trial data is useless, too much, and the patient is in danger.
  2. 3M Expands Inhalation Portfolio With New Solutions for pMDIs 6/9/2009
    3M Drug Delivery Systems introduces two new innovations for inhalation drug delivery with pressurized metered dose inhalers (pMDIs)—3M Plasma Coating Technology and the 3M Face Seal Valve.
  3. Quanticate Partners With Atlantic-Global To Offer Project Portfolio Management Services 5/27/2009
    Quanticate., recently announced it has partnered with Atlantic-Global, a leading provider of integrated business and resource software, to produce a customized, fully web-enabled Project Portfolio Management System.
  4. Sandoz To Acquire EBEWE Pharma Specialty Generics Business, Improving Access For Patients Worldwide To Injectable Cancer Drugs 5/21/2009
    Novartis has signed a definitive agreement to acquire the specialty generic injectables business of EBEWE Pharma, providing Sandoz - the Group's generic pharmaceuticals division - an opportunity to create a strong global platform for future growth while improving access for patients worldwide to many generic oncology medicines.
  5. Baxter Announces Findings From Premix Heparin IV Bag Investigation Related To Beebe Medical Center Adverse Event Reports 5/19/2009
    Recently, Baxter is announcing that its investigation of reports from Beebe Medical Center has determined that the three patient events are unrelated to product quality involving the company’s heparin premix products.
  6. Licaps® Drug Delivery System At GSK Allows Rapid In-House Manufacture of Capsules With A High Integrity Seal 5/14/2009
    Capsugel, the world’s leading provider of dosage form solutions to the pharmaceutical and related healthcare industries, is delighted to announce that its integrated Licaps® Drug Delivery System of Licaps® capsules and Liquid Encapsulation Microspray Sealing (LEMS®) equipment is being successfully used in major healthcare company, GlaxoSmithKline (GSK) to produce new capsule lines with a proven secure seal.
  7. The Medicines Company Discontinues Phase 3 CHAMPION Clinical Trial Program Of Cangrelor 5/14/2009
    The Medicines Company today announced that it is discontinuing its Phase 3 CHAMPION clinical trial program of cangrelor in patients undergoing percutaneous coronary intervention (PCI).
  8. GSK Extends Strategic Collaboration With Aspen 5/14/2009
    GlaxoSmithKline plc (GSK) recently announced that it has agreed to extend its strategic relationship with Aspen Pharmacare Holdings Limited (Aspen) and to acquire a 16% shareholding in the South African based pharmaceuticals company.
  9. Prefilled WFI Syringe Provides A High-Quality Solution For Drug Reconstitution 5/12/2009
    West (NYSE: WST), the world’s premier manufacturer of components and systems for injectable drug delivery, and Vetter, a worldwide leading independent specialist in the contract manufacturing of prefilled application systems, have introduced a ready-to-use, WFI prefilled syringe for reconstituting lyophilized drug products.
  10. Tekmira Pharmaceuticals Receives Clearance From FDA To Initiate ApoB SNALP Phase 1 Clinical Trial 5/11/2009
    Tekmira Pharmaceuticals Corporation announced recently that its Investigational New Drug (IND) application for ApoB SNALP has been cleared by the United States Food and Drug Administration (FDA) allowing Tekmira to begin enrolling patients in a Phase 1 human clinical trial.